化疗,佐剂的临床试验
总计1262个结果
-
Martin-Luther-Universität Halle-Wittenberg完全的
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Shanghai Zhongshan HospitalFirst Affiliated Hospital of Wenzhou Medical University; Anhui Provincial Hospital; Shanghai Minhang...招聘中
-
Dana-Farber Cancer InstituteGilead Sciences; AstraZeneca; Eisai Inc.; Paxman Coolers Limited; Daiichi Sankyo招聘中
-
Eisai Inc.完全的确诊恶性疾病接受低致吐化疗 (LEC) 或在 LEC 的最后一个周期中至少出现恶心和呕吐的患者美国
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer Hospital; Tianjin... 和其他合作者完全的
-
Myelo Therapeutics GmbH完全的
-
Mashhad University of Medical Sciences完全的
-
SandozSandoz GmbH完全的乳腺肿瘤 | 化疗毒性 | 化疗引起的中性粒细胞减少症 | 中性粒细胞减少并发症俄罗斯联邦, 巴西, 印度, 墨西哥, 罗马尼亚, 乌克兰
-
Sultan Abdulhamid Han Training and Research Hospital...招聘中
-
West China Hospital招聘中新辅助化疗 | High-risk Locally Advanced Colorectal Cancer | FOLFOXIRI Regimen中国
-
Guangdong Provincial People's Hospital招聘中
-
University Clinical Centre, GdanskNutricia Foundation未知
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的热疗 | Therapeutic Hyperthermia | Polymers巴西
-
Zealand University Hospital招聘中
-
McGill University Health Centre/Research Institute...未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Aileron Therapeutics, Inc.终止
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
The Affiliated Hospital of Qingdao University招聘中
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University... 和其他合作者尚未招聘
-
Zunyi Medical CollegeGuizhou Provincial People's Hospital; Sichuan Cancer Hospital and Research Institute; Zunyi First... 和其他合作者招聘中
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New Jersey完全的
-
St. James's Hospital, IrelandKarolinska Institutet; St Mary's Hospital, Paddington, London完全的
-
University of Pennsylvania完全的
-
Medical University of Silesia完全的
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁